本次交易完成后，本集团对中集世联达持股比例将由62.70%下降至45.04%。为确保本集团在本次交易 后继续併表中集世联达，2025年12月31日，本公司与中集世联达的管理层持股平台—集智共创及集联 (本次交易完成后分别持有中集世联达8.22%和1.89%股份)签订了《股东一致行动协议》。 本次交易的必要性：中集世联达正处于业务升级发展的关键阶段，为支持中集世联达战略落地，进一步 扩大业务规模和提升盈利能力，中集世联达计划增资扩充股本，并引入更多有优质资源的战略投资人， 以扩大资本助力其高质量持续发展。后续随着融资渠道的拓宽，中集世联达可促进巩固其市场地位，提 升市场份额和盈利能力，同时有利于本集团股东价值的最大化。 中集世联达旗下子公司的小股东股权上翻尚需对该等子公司的股权价值另行评估，本公司后续将及时履 行相关的信息披露义务。 中集集团（000039）(02039)发布公告，本公司获悉，本公司附属公司中集世联达(即目标公司)拟通过增 资扩股和转让少量老股的方式引入战略投资者。2025年12月31日，经第十一届董事会2025年度第17次会 议审议通过，本公司与中集世联达、现有股东及新股东签订了《股东协议》及 ...

（编辑 袁冠琳） 证券日报网讯 12月10日，尤洛卡在互动平台回答投资者提问时表示，军工业务引入战略投资者是公司 一项长期且审慎的战略行为，如有实质性进展并达到信息披露标准，公司将严格按照相关法律法规及监 管要求及时履行信息披露义务。 ...

Group 1 - The core point of the announcement is the adjustment of the strategic investor introduction plan for Jinkai Zhihui (Ningxia) Technology Co., Ltd., a subsidiary of Jinkai New Energy Co., Ltd. The plan will now be implemented in steps rather than simultaneously [2][5][21] - The initial plan involved transferring 70% of Jinkai Zhihui's equity at a minimum price of 120.0385 million yuan and increasing its registered capital by 10 million yuan, with a minimum investment of 34.3 million yuan [4] - The adjustment was approved by the company's board of directors, and the final transaction price will depend on the bidding price at the property rights trading center, indicating uncertainty in the transaction's implementation [3][21] Group 2 - Jinkai New Energy's subsidiary, Jinkai Limited, plans to introduce a strategic investor for Urumqi Ruihe Guangsheng Electric Power Technology Co., Ltd. by transferring 51% of its equity, with an expected investment return of approximately 131 million yuan [8][10][11] - The transaction has been approved by the company's board and will not constitute a related party transaction or a major asset restructuring [9][12] - The estimated value of Ruihe Guangsheng's total equity is 305.5853 million yuan, with the transfer price set at no less than 155.8485 million yuan [10][14][16]

转自：证券时报 人民财讯11月27日电，金开新能(600821)11月27日公告，全资子公司金开有限拟通过公开挂牌的方式为 其全资子公司瑞和光晟引入战略投资者。本次交易拟转让标的公司51%股权，股权转让后预计可实现投 资收益约1.31亿元。本次交易完成后，金开有限对瑞和光晟的持股比例为49%，瑞和光晟将不再纳入公 司合并报表范围。 ...

Group 1 - The controlling shareholder of Sanrenxing (605168.SH), Qingdao Duoduo Xing, along with actual controllers Qian Jundong and Cui Lei, plan to reduce their holdings by transferring no more than 16.8654 million shares, accounting for no more than 8% of the total share capital [1] - The purpose of the transfer is to introduce strategic investors and optimize the equity structure of the company [1]

Core Viewpoint - The company is considering the possibility of introducing Hangzhou Jinjiang Group as a strategic investor, given its status as a leading player in the national aluminum industry [1] Group 1 - Hangzhou Jinjiang Group is recognized as a leader in the aluminum industry in China [1]

Core Viewpoint - The company has approved a plan for its wholly-owned subsidiary, Guangzhou Haige Tianteng Industrial Development Co., Ltd., to raise capital through public listing and introduce strategic investors, with a maximum capital increase amount of 800 million RMB [2][6]. Group 1: Meeting and Decision - The sixth board meeting of the company was held on November 13, 2025, where all nine directors participated in the voting, resulting in unanimous approval for the capital increase proposal [1][3]. - The decision-making process complied with the relevant provisions of the Company Law and the Articles of Association [1]. Group 2: Capital Increase Details - The capital increase will be conducted through the Guangzhou Property Rights Exchange, with the final transaction details remaining uncertain [6][12]. - The maximum amount for the capital increase is set at 800 million RMB, and the new investors will hold no more than 43.44% of the subsidiary's equity after the increase [6][12]. Group 3: Financial and Operational Impact - The subsidiary, Tianteng Industrial, is crucial for the company's industrial base construction and the capital increase is aimed at meeting its operational funding needs, enhancing competitiveness, and accelerating development in the unmanned and low-altitude economy sectors [15]. - The company will maintain its controlling stake in Tianteng Industrial post-capital increase, ensuring no significant adverse impact on its operations [15]. Group 4: Company and Subsidiary Information - Tianteng Industrial was established on February 18, 2022, with a registered capital of 900 million RMB and is located in Guangzhou [8]. - The company currently holds 100% equity in Tianteng Industrial, which will remain within the consolidated financial statements after the capital increase [9][7].

Core Viewpoint - Nanjing Public Utilities (000421) announced a non-public agreement to transfer 43.731 million shares, representing 7.61% of the total share capital, to Nanjing Innovation Investment Group for a total consideration of 300 million yuan [1] Group 1 - The controlling shareholder, Nanjing Public Utilities Holdings (Group) Co., Ltd., and its concerted party, Nanjing Urban Construction Investment Holdings (Group) Co., Ltd., will not change after the equity transfer [1] - The new shareholder, Nanjing Innovation Investment Group, focuses on the "4266" industry in Nanjing and aims to enhance project investment and industrial mergers and acquisitions efficiency [1] - The transaction is expected to facilitate the company's capital operations, leading to rapid market transformation and sustained performance growth [1] Group 2 - Following the completion of the transaction, the acquirer will nominate or recommend one non-independent director to the company [1]

Core Viewpoint - The company, Jilin Aodong Pharmaceutical Group Co., Ltd., has disclosed its third-quarter financial report for 2025, ensuring the accuracy and completeness of the information presented [1][2][10]. Financial Data - The third-quarter financial report has not been audited [3][7]. - The company does not require retrospective adjustments or restatements of previous accounting data [3]. - There are no non-recurring profit and loss items applicable for the reporting period [3][4]. Shareholder Information - The total number of ordinary shareholders and the situation of the top ten shareholders have been reported, but there are no changes due to securities lending activities [5][6]. Board Meeting - The 19th meeting of the 11th Board of Directors was held on October 30, 2025, with all nine directors present [8][9]. - The board approved the third-quarter report and the proposal to adjust external investments and introduce strategic investors, with unanimous support [10][12][26]. Investment Adjustment - The company plans to adjust its external investments and introduce strategic investors to optimize the capital structure of its subsidiary, Aodong Pharmaceutical (Anhui) Co., Ltd. [16][22]. - The registered capital of Aodong Anhui will be reduced from 300 million yuan to 20 million yuan, with the company terminating its planned investment of 3 million yuan [18][20]. - A new strategic investor, Zhongneng Shuzhi Technology (Shanghai) Co., Ltd., will be introduced, holding 40% of the shares [20][22]. Purpose and Impact of Adjustment - The adjustment aims to focus on core business development and enhance market competitiveness, particularly in key regions like Shanghai [22]. - The company believes this adjustment will optimize resource allocation and control investment risks, aligning with its long-term strategic interests [24].

Core Insights - The company has a limited direct export proportion to the United States, indicating a diversified customer base [1] - To mitigate the impact of tariffs, the company has established a production base in Vietnam [1] - The introduction of strategic investors requires mutual interest, and the company is open to potential investors [1]